Tapewire

NYSE · USD

NVST

Envista Holdings Corp

Export transactions ↓
Tapewire entity
4007
SEC CIK
0001757073
Parsed reports
315

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 25, 2026 Filed Aug 27, 2026 20:19 UTC
Nilsson StefanPresident, Nobel Biocare
Tax withholdingCommon Stock 804 $27.47 $22,085.88
Disclosure

SEC source: 0002045818-26-000005 · wk-form4_1787861937.xml · nonDerivative · entry 1

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,560

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 20:25 UTC
Acurio VeronicaPresident, Orthodontics
Tax withholdingCommon Stock 7,710 $27.47 $211,793.70
Disclosure

SEC source: 0002045846-26-000007 · wk-form4_1787862328.xml · nonDerivative · entry 1

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,806

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 20:23 UTC
Befidi RobertPresident, Diagnostics
Tax withholdingCommon Stock 5,147 $27.47 $141,388.09
Disclosure

SEC source: 0002012361-26-000007 · wk-form4_1787862196.xml · nonDerivative · entry 1

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,785

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 20:21 UTC
Hammes Eric D.Chief Financial Officer
Tax withholdingCommon Stock 10,885 $27.47 $299,010.95
Disclosure

SEC source: 0001610493-26-000009 · wk-form4_1787862063.xml · nonDerivative · entry 1

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,913

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 20, 2026 Filed Aug 24, 2026 20:25 UTC
Reis MischaSVP, Strategy & Bus. Dev.
SaleCommon Stock 8,000 $27.50 $220,000.00
Disclosure

SEC source: 0001788632-26-000009 · wk-form4_1787603134.xml · nonDerivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,321

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

Read SEC document
August 18, 2026 Filed Aug 20, 2026 20:15 UTC
Hammes Eric D.Chief Financial Officer
GrantPerformance Share Unit · Derivative 47,970 $0.00 $0.00
Disclosure

SEC source: 0001610493-26-000007 · wk-form4_1787256898.xml · derivative · entry 1

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,970

Underlying: Common Stock · 47,970 shares

Expires not disclosed

F1 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.

F1 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.

F1 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.

Read SEC document
August 18, 2026 Filed Aug 20, 2026 20:15 UTC
Keel Paul ADirector · Chief Executive Officer
GrantPerformance Share Unit · Derivative 159,900 $0.00 $0.00
Disclosure

SEC source: 0001626337-26-000010 · wk-form4_1787256919.xml · derivative · entry 2

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,900

Underlying: Common Stock · 159,900 shares

Expires not disclosed

F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.

F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.

F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.

Read SEC document
August 18, 2026 Filed Aug 20, 2026 20:15 UTC
Keel Paul ADirector · Chief Executive Officer
GrantCommon Stock 179,730 $0.00 $0.00
Disclosure

SEC source: 0001626337-26-000010 · wk-form4_1787256919.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 551,304

F1 · shares: Consists of Restricted Stock Units ("RSU") that will vest ratably on each anniversary of the date of grant over four years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
May 25, 2026 Filed May 27, 2026 20:17 UTC
Keel Paul ADirector · Chief Executive Officer
Tax withholdingCommon Stock 12,811 $23.43 $300,161.73
Disclosure

SEC source: 0001626337-26-000005 · wk-form4_1779913032.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,574

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:37 UTC GrantCommon Stock 9,330 $0.00 $0.00
Disclosure

SEC source: 0001886518-26-000007 · wk-form4_1779395820.xml · nonDerivative · entry 1

Pierce James Andrew · CIK 0001886518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,485

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:37 UTC
Jain VivekDirector
GrantCommon Stock 9,330 $0.00 $0.00
Disclosure

SEC source: 0001410442-26-000005 · wk-form4_1779395833.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,945

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:37 UTC GrantCommon Stock 9,330 $0.00 $0.00
Disclosure

SEC source: 0001278861-26-000008 · wk-form4_1779395841.xml · nonDerivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,930

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:36 UTC GrantCommon Stock 9,330 $0.00 $0.00
Disclosure

SEC source: 0001306860-26-000003 · wk-form4_1779395811.xml · nonDerivative · entry 1

Raskas Daniel · CIK 0001306860 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,010

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:37 UTC GrantCommon Stock 9,330 $0.00 $0.00
Disclosure

SEC source: 0001308428-26-000003 · wk-form4_1779395827.xml · nonDerivative · entry 1

GALLAHUE KIERAN · CIK 0001308428 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,010

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:36 UTC GrantCommon Stock 12,585 $0.00 $0.00
Disclosure

SEC source: 0001365493-26-000003 · wk-form4_1779395802.xml · nonDerivative · entry 1

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,105

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:37 UTC GrantCommon Stock 9,330 $0.00 $0.00
Disclosure

SEC source: 0001563565-26-000003 · wk-form4_1779395847.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,940

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Nilsson StefanPresident, Nobel Biocare
GrantEmployee Stock Option (Right to Buy) · Derivative 18,020 $0.00 Strike: $29.59 $0.00
Disclosure

SEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · derivative · entry 4

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,020

Underlying: Common Stock · 18,020 shares

Expires 2036-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Nilsson StefanPresident, Nobel Biocare
GrantPerformance Share Unit · Derivative 13,845 $0.00 $0.00
Disclosure

SEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · derivative · entry 3

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,845

Underlying: Common Stock · 13,845 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Nilsson StefanPresident, Nobel Biocare
GrantCommon Stock 7,605 $0.00 $0.00
Disclosure

SEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · nonDerivative · entry 2

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,364

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Nilsson StefanPresident, Nobel Biocare
Tax withholdingCommon Stock 182 $29.59 $5,385.38
Disclosure

SEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · nonDerivative · entry 1

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,759

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Acurio VeronicaPresident, Orthodontics
GrantEmployee Stock Option (Right to Buy) · Derivative 18,020 $0.00 Strike: $29.59 $0.00
Disclosure

SEC source: 0002045846-26-000004 · wk-form4_1772227178.xml · derivative · entry 4

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,020

Underlying: Common Stock · 18,020 shares

Expires 2036-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Acurio VeronicaPresident, Orthodontics
GrantPerformance Share Unit · Derivative 13,845 $0.00 $0.00
Disclosure

SEC source: 0002045846-26-000004 · wk-form4_1772227178.xml · derivative · entry 3

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,845

Underlying: Common Stock · 13,845 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Acurio VeronicaPresident, Orthodontics
GrantCommon Stock 7,605 $0.00 $0.00
Disclosure

SEC source: 0002045846-26-000004 · wk-form4_1772227178.xml · nonDerivative · entry 2

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,516

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Acurio VeronicaPresident, Orthodontics
Tax withholdingCommon Stock 1,412 $29.59 $41,781.08
Disclosure

SEC source: 0002045846-26-000004 · wk-form4_1772227178.xml · nonDerivative · entry 1

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,911

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Befidi RobertPresident, Diagnostics
GrantEmployee Stock Option (Right to Buy) · Derivative 18,020 $0.00 Strike: $29.59 $0.00
Disclosure

SEC source: 0002012361-26-000004 · wk-form4_1772227143.xml · derivative · entry 4

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,020

Underlying: Common Stock · 18,020 shares

Expires 2036-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Befidi RobertPresident, Diagnostics
GrantPerformance Share Unit · Derivative 13,845 $0.00 $0.00
Disclosure

SEC source: 0002012361-26-000004 · wk-form4_1772227143.xml · derivative · entry 3

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,845

Underlying: Common Stock · 13,845 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Befidi RobertPresident, Diagnostics
GrantCommon Stock 7,605 $0.00 $0.00
Disclosure

SEC source: 0002012361-26-000004 · wk-form4_1772227143.xml · nonDerivative · entry 2

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,932

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Befidi RobertPresident, Diagnostics
Tax withholdingCommon Stock 2,177 $29.59 $64,417.43
Disclosure

SEC source: 0002012361-26-000004 · wk-form4_1772227143.xml · nonDerivative · entry 1

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,327

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2026 Filed Feb 27, 2026 16:19 UTC
Kaabi Faez CChief Accounting Officer
GrantCommon Stock 13,520 $0.00 $0.00
Disclosure

SEC source: 0001993528-26-000003 · wk-form4_1772227153.xml · nonDerivative · entry 2

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,552

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 16:19 UTC
Kaabi Faez CChief Accounting Officer
Tax withholdingCommon Stock 4,964 $29.59 $146,884.76
Disclosure

SEC source: 0001993528-26-000003 · wk-form4_1772227153.xml · nonDerivative · entry 1

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,032

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs").

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Hammes Eric D.Chief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 38,040 $0.00 Strike: $29.59 $0.00
Disclosure

SEC source: 0001610493-26-000004 · wk-form4_1772227184.xml · derivative · entry 4

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,040

Underlying: Common Stock · 38,040 shares

Expires 2036-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Hammes Eric D.Chief Financial Officer
GrantPerformance Share Unit · Derivative 29,225 $0.00 $0.00
Disclosure

SEC source: 0001610493-26-000004 · wk-form4_1772227184.xml · derivative · entry 3

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,225

Underlying: Common Stock · 29,225 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Hammes Eric D.Chief Financial Officer
GrantCommon Stock 16,055 $0.00 $0.00
Disclosure

SEC source: 0001610493-26-000004 · wk-form4_1772227184.xml · nonDerivative · entry 2

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,798

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Hammes Eric D.Chief Financial Officer
Tax withholdingCommon Stock 2,045 $29.59 $60,511.55
Disclosure

SEC source: 0001610493-26-000004 · wk-form4_1772227184.xml · nonDerivative · entry 1

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,743

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Keel Paul ADirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 115,320 $0.00 Strike: $29.59 $0.00
Disclosure

SEC source: 0001626337-26-000004 · wk-form4_1772227148.xml · derivative · entry 4

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,320

Underlying: Common Stock · 115,320 shares

Expires 2036-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Keel Paul ADirector · Chief Executive Officer
GrantPerformance Share Unit · Derivative 132,885 $0.00 $0.00
Disclosure

SEC source: 0001626337-26-000004 · wk-form4_1772227148.xml · derivative · entry 3

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,885

Underlying: Common Stock · 132,885 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Keel Paul ADirector · Chief Executive Officer
GrantCommon Stock 48,670 $0.00 $0.00
Disclosure

SEC source: 0001626337-26-000004 · wk-form4_1772227148.xml · nonDerivative · entry 2

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,385

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Keel Paul ADirector · Chief Executive Officer
Tax withholdingCommon Stock 11,840 $29.59 $350,345.60
Disclosure

SEC source: 0001626337-26-000004 · wk-form4_1772227148.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,715

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2026 Filed Feb 27, 2026 16:19 UTC
Nance Mark EGeneral Counsel
GrantEmployee Stock Option (Right to Buy) · Derivative 30,040 $0.00 Strike: $29.59 $0.00
Disclosure

SEC source: 0001755882-26-000004 · wk-form4_1772227158.xml · derivative · entry 4

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,040

Underlying: Common Stock · 30,040 shares

Expires 2036-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 16:19 UTC
Nance Mark EGeneral Counsel
GrantPerformance Share Unit · Derivative 23,070 $0.00 $0.00
Disclosure

SEC source: 0001755882-26-000004 · wk-form4_1772227158.xml · derivative · entry 3

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,070

Underlying: Common Stock · 23,070 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 16:19 UTC
Nance Mark EGeneral Counsel
GrantCommon Stock 12,675 $0.00 $0.00
Disclosure

SEC source: 0001755882-26-000004 · wk-form4_1772227158.xml · nonDerivative · entry 2

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,252

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 16:19 UTC
Nance Mark EGeneral Counsel
Tax withholdingCommon Stock 3,368 $29.59 $99,659.12
Disclosure

SEC source: 0001755882-26-000004 · wk-form4_1772227158.xml · nonDerivative · entry 1

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,577

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantEmployee Stock Option (Right to Buy) · Derivative 14,020 $0.00 Strike: $29.59 $0.00
Disclosure

SEC source: 0001788632-26-000006 · wk-form4_1772227166.xml · derivative · entry 4

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,020

Underlying: Common Stock · 14,020 shares

Expires 2036-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantPerformance Share Unit · Derivative 10,770 $0.00 $0.00
Disclosure

SEC source: 0001788632-26-000006 · wk-form4_1772227166.xml · derivative · entry 3

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,770

Underlying: Common Stock · 10,770 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantCommon Stock 5,915 $0.00 $0.00
Disclosure

SEC source: 0001788632-26-000006 · wk-form4_1772227166.xml · nonDerivative · entry 2

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,321

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:19 UTC
Reis MischaSVP, Strategy & Bus. Dev.
Tax withholdingCommon Stock 2,976 $29.59 $88,059.84
Disclosure

SEC source: 0001788632-26-000006 · wk-form4_1772227166.xml · nonDerivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,406

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 10, 2026 Filed Feb 11, 2026 22:15 UTC
Reis MischaSVP, Strategy & Bus. Dev.
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,634 $0.00 Strike: $15.97 $0.00
Disclosure

SEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · derivative · entry 6

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,634 shares

Expires 2027-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation.

F4 · derivative.exercise_date: This Option was fully vested as of May 15, 2022.

Read SEC document
February 10, 2026 Filed Feb 11, 2026 22:15 UTC
Reis MischaSVP, Strategy & Bus. Dev.
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,041 $0.00 Strike: $19.04 $0.00
Disclosure

SEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · derivative · entry 5

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,041 shares

Expires 2028-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation.

F3 · derivative.exercise_date: This Option was fully vested as of February 24, 2023.

Read SEC document
February 10, 2026 Filed Feb 11, 2026 22:15 UTC
Reis MischaSVP, Strategy & Bus. Dev.
SaleCommon Stock 5,634 $30.00 $169,020.00
Disclosure

SEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · nonDerivative · entry 4

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,382

F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

Read SEC document
February 10, 2026 Filed Feb 11, 2026 22:15 UTC
Reis MischaSVP, Strategy & Bus. Dev.
Exercise / conversionCommon Stock 5,634 $15.97 $89,974.98
Disclosure

SEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · nonDerivative · entry 3

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.